Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 6 | -541K | 100% | $23.87 | -$12.9M |
Net | -6 | -541K | -100% | -$12.9M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Sanj K. Patel | CHAIRMAN & CEO, Director | $8.56M | -$5.25M | -38% | Sep 1, 2024 |
Eben Tessari | Chief Operating Officer | $5.28M | -$934K | -15% | Sep 23, 2024 |
John F. Paolini | Chief Medical Officer | $2.37M | -$3.29M | -58.2% | Sep 1, 2024 |
Michael R. Megna | Chief Accounting Officer | $1.09M | -$817K | -42.9% | Jul 15, 2024 |
Mark Ragosa | Chief Financial Officer | $1.05M | -$841K | -44.5% | Sep 1, 2024 |
Ross Moat | Chief Commercial Officer | $981K | -$1.79M | -64.6% | Jul 15, 2024 |
Richard S. Levy | Director | $231K | Jun 5, 2024 | ||
Kimberly J. Popovits | Director | $168K | Jun 5, 2024 | ||
Tracey L. McCain | Director | $168K | Jun 5, 2024 | ||
G. Bradley Cole | Director | $168K | Jun 5, 2024 | ||
Barry D. Quart | Director | $168K | Jun 5, 2024 | ||
Baker Bros. Advisors Lp | Director | Jun 5, 2024 | |||
Arian Pano | Chief Clinical Dev. Officer | Sep 2, 2021 | |||
Thomas Malley | Director | Jun 5, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|